GSA Capital Partners’s Day One Biopharmaceuticals DAWN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $413K | Buy |
63,546
+19,843
| +45% | +$129K | 0.03% | 1048 |
|
|
2025
Q1 | $347K | Sell |
43,703
-54,327
| -55% | -$431K | 0.03% | 1044 |
|
|
2024
Q4 | $1.24M | Buy |
98,030
+38,771
| +65% | +$491K | 0.09% | 268 |
|
|
2024
Q3 | $825K | Buy |
+59,259
| New | +$825K | 0.06% | 591 |
|
|
2024
Q1 | – | Sell |
-30,378
| Closed | -$444K | – | 1686 |
|
|
2023
Q4 | $444K | Buy |
+30,378
| New | +$444K | 0.04% | 872 |
|
|
2023
Q2 | – | Sell |
-36,494
| Closed | -$488K | – | 1591 |
|
|
2023
Q1 | $488K | Buy |
+36,494
| New | +$488K | 0.05% | 734 |
|